COMPOSES MULTIHETEROARYLES SERVANT D'INHIBITEURS DE LA H-PGDS, AINSI QUE LEUR UTILISATION DANS LE TRAITEMENT DES MALADIES INDUITES PAR LA PROSTAGLANDINE D2
Multiheteroaryl compounds, their preparation, pharmaceutical compositions comprising these compounds, and their pharmaceutical use in the prevention and treatment of prostaglandin D2 mediated diseases and conditions that may be modulated by the inhibition of hematopoietic prostaglandin D synthase (H-PGDS).